Here you’ll find everything you need to know from MM&M’s January 2017 issue, including our health-tech preview, a deep dive into data science, and report on digital innovation from Japanese drugmakers.
If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold
Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.
Infographic: Can pharma give doctors what they want?
January 11, 2017
12:00 pm
Physicians do not like EHRs. That much is clear. But the vast majority have to use electronic record systems on a daily basis. What can pharma do to better give doctors what they want?
When it comes to PCSK9s, payers resisted — and sales flopped
The first two PCSK9s landed with a thud. What does their disappointing launch say about the need for marketers of CV drugs to get their pricing houses in order?
Despite their blockbuster status and distinction as the world’s most widely prescribed class of drugs, statins may not be the best option for all patients with elevated low density lipoprotein (LDL) cholesterol levels.
Harness the Power of Paranoia to Disrupt Your Business